Evaluation of circulating tumor cells and related events as prognostic factors and surrogate biomarkers in advanced NSCLC patients receiving first-line systemic treatment

1. Muinelo-Romay, L.
2. Vieito, M.
3. Abalo, A.
4. Nocelo, M.A.
5. Barón, F.
6. Anido, U.
7. Brozos, E.
8. Vázquez, F.
9. Aguín, S.
10. Abal, M.
11. López, R.L.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3390/CANCERS6010153 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus